Evofem Biosciences, Inc.
EVFM
$0.01
$0.002.27%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 93.07% | 2.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 93.07% | 2.63% | |||
| Cost of Revenue | 186.41% | 19.87% | |||
| Gross Profit | 72.20% | -0.57% | |||
| SG&A Expenses | -29.40% | 0.25% | |||
| Depreciation & Amortization | 11.25% | -25.23% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.75% | -2.34% | |||
| Operating Income | 440.63% | 21.50% | |||
| Income Before Tax | 277.18% | 11.48% | |||
| Income Tax Expenses | 75.00% | -157.14% | |||
| Earnings from Continuing Operations | 277.69% | 12.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 277.69% | 12.05% | |||
| EBIT | 440.63% | 21.50% | |||
| EBITDA | 482.96% | 21.23% | |||
| EPS Basic | 236.43% | 9.09% | |||
| Normalized Basic EPS | 165.03% | -90.63% | |||
| EPS Diluted | 101.43% | 30.00% | |||
| Normalized Diluted EPS | 100.55% | -90.63% | |||
| Average Basic Shares Outstanding | 22.05% | 3.36% | |||
| Average Diluted Shares Outstanding | 21,089.75% | 3.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||